Literature DB >> 31179073

The impact of low forced vital capacity on behavior restrictions in a population with airflow obstruction.

Noeul Kang1, Sun Hye Shin1, Seonhye Gu2, Danbee Kang2,3, Juhee Cho2,3,4, Ho Jung Jeong5, Gee Young Suh1, Hyun Lee6, Hye Yun Park1.   

Abstract

BACKGROUND: Recent studies have suggested that low forced vital capacity (FVC) is related to respiratory symptoms with various comorbid conditions that eventually lead to physical inactivity and may be applied to subjects with airflow obstruction (AO). Therefore, this study aimed to evaluate the association between low FVC and behavior restrictions in subjects with AO.
METHODS: A cross-sectional study was performed using data from the Korea National Health and Nutrition Survey conducted between 2007 and 2015. Participants aged 40 to 79 years with spirometry-defined AO (pre-bronchodilator forced expiratory volume in one second/FVC <70%) were analyzed to evaluate the association between low FVC (defined as FVC <80% predicted) and behavior restrictions.
RESULTS: A total of 3,345 participants with AO were included. The proportion of subjects with low FVC varied widely according to severity of airflow limitation (0.9%, 35.5%, and 85.1% in the mild, moderate, and severe-to-very-severe AO groups, respectively). Compared to the moderate AO group with normal FVC, those with low FVC were more likely to be older, to be never- or ex-smokers, to have larger waist size with higher body mass index, and to have comorbidities such as diabetes, hypertension, dyslipidemia, and osteoporosis. Low FVC was independently associated with behavior restrictions [adjusted prevalence ratio (aPR), 1.72; 95% confidence interval (CI), 1.43-2.06] among all participants with AO, and this was most prominent in those with moderate AO (aPR, 1.65; 95% CI, 1.27-2.13).
CONCLUSIONS: In subjects with moderate AO, low FVC was independently associated with behavior restrictions even after adjusting for confounding factors.

Entities:  

Keywords:  Airflow obstruction (AO); forced vital capacity (FVC); physical activity

Year:  2019        PMID: 31179073      PMCID: PMC6531733          DOI: 10.21037/jtd.2019.03.77

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  33 in total

1.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.

Authors:  Judith Garcia-Aymerich; Peter Lange; Marta Benet; Peter Schnohr; Josep M Antó
Journal:  Am J Respir Crit Care Med       Date:  2006-12-07       Impact factor: 21.405

4.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

Authors:  J Garcia-Aymerich; P Lange; M Benet; P Schnohr; J M Antó
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

5.  Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model.

Authors:  Judith Garcia-Aymerich; Peter Lange; Ignasi Serra; Peter Schnohr; Josep M Antó
Journal:  Ann Epidemiol       Date:  2008-08-16       Impact factor: 3.797

Review 6.  Why does the lung hyperinflate?

Authors:  Gary T Ferguson
Journal:  Proc Am Thorac Soc       Date:  2006-04

7.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

Authors:  Fabio Pitta; Thierry Troosters; Martijn A Spruit; Vanessa S Probst; Marc Decramer; Rik Gosselink
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

8.  Physical activity and hospitalization for exacerbation of COPD.

Authors:  Fabio Pitta; Thierry Troosters; Vanessa S Probst; Martijn A Spruit; Marc Decramer; Rik Gosselink
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

9.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

Authors:  J Garcia-Aymerich; E Farrero; M A Félez; J Izquierdo; R M Marrades; J M Antó
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

10.  Lung function impairment and metabolic syndrome: the critical role of abdominal obesity.

Authors:  Nathalie Leone; Dominique Courbon; Frédérique Thomas; Kathy Bean; Bertrand Jégo; Bénédicte Leynaert; Louis Guize; Mahmoud Zureik
Journal:  Am J Respir Crit Care Med       Date:  2009-01-08       Impact factor: 21.405

View more
  2 in total

1.  Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease.

Authors:  Seong Mi Moon; Jun Hyeok Lim; Yun Soo Hong; Kyeong-Cheol Shin; Chang Youl Lee; Do Jin Kim; Sang Haak Lee; Ki Suck Jung; Chang-Hoon Lee; Kwang Ha Yoo; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 3.005

2.  Small airway dysfunction on impulse oscillometry and pathological signs on lung ultrasound are frequent in post-COVID-19 patients with persistent respiratory symptoms.

Authors:  Agnaldo José Lopes; Patrícia Frascari Litrento; Bruna Cuoco Provenzano; Alícia Sales Carneiro; Laura Braga Monnerat; Mariana Soares da Cal; Angelo Thomaz Abalada Ghetti; Thiago Thomaz Mafort
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.